Results 11 to 20 of about 19,110 (253)

Liraglutide Ameliorates Injury-Related Vascular Repair by Activating Autophagy Through Modulation of the PI3K-mTOR Signaling Pathway. [PDF]

open access: yesFASEB J
Liraglutide inhibits chronic stress‐induced vascular injury in mice by inhibiting the activation of the PI3K‐mTOR signaling pathway and promoting autophagy of smooth muscle cells or macroautophagy. ABSTRACT Chronic stress is a significant risk factor for postoperative restenosis and other cardiovascular diseases, as it can promote the intimal ...
Zhang Z   +14 more
europepmc   +2 more sources

Carotid artery stenting using CASPER has a lower incidence of ischemic complications compared to Carotid WALLSTENT, but there is no significant difference in postoperative restenosis. [PDF]

open access: greenInterv Neuroradiol
Fujii T   +12 more
europepmc   +3 more sources

Stent-in-Stent Endovascular Correction in Right Internal Carotid Artery Restenosis: a Clinical Case

open access: yesКреативная хирургия и онкология, 2021
Background. Carotid artery restenosis is a rare complication of carotid stenting. The Carotid Revascularization Endarterectomy versus Stenting Trial (CREST) reveals an in-stent restenosis rate of 0–6 %, a fairly low value given an extensive study ...
T. N. Khafizov   +6 more
doaj   +1 more source

Role of carotid duplex in the assessment of carotid artery restenosis after endarterectomy or stenting

open access: yesFrontiers in Neurology, 2023
IntroductionRedo carotid endarterectomy (CEA) and carotid stenting (CAS) are often performed when there is evidence of post-procedural restenosis. The incidence of restenosis after carotid reconstruction is not negligible, ranging from 5 to 33%.
István Szegedi   +5 more
doaj   +1 more source

Association between platelet lymphocyte ratio and neutrophil lymphocyte ratio and clinical outcomes following carotid endarterectomy [PDF]

open access: yesJornal Vascular Brasileiro, 2023
Background Approximately 30% of stroke cases result from carotid disease. Although several risk factors for complications after carotid endarterectomy have been identified, the existence of a biomarker that can estimate postoperative risk in these ...
Vinicius Adorno Gonçalves   +3 more
doaj   +1 more source

The preoperative triglyceride-glucose index has a positive effect on predicting the risk of short-term restenosis after carotid artery stenting: a retrospective cohort study

open access: yesFrontiers in Neurology, 2023
BackgroundIncreasing evidence suggests that insulin resistance is linked to cardiovascular disease and atherosclerosis. The triglyceride–glucose (TyG) index has proven to be a convincing marker to quantitatively evaluate insulin resistance.
Shan-shan Zhao   +4 more
doaj   +1 more source

Computed poststenotic flow instabilities correlate phenotypically with vibrations measured using laser Doppler vibrometry : perspectives for a promising in vivo device for early detection of moderate and severe carotid stenosis [PDF]

open access: yes, 2020
Early detection of asymptomatic carotid stenosis is crucial for treatment planning in the prevention of ischemic stroke. Auscultation, the current first-line screening methodology, comes with severe limitations that create urge for novel and robust ...
Mancini, Viviana   +3 more
core   +2 more sources

Open surgical repair for in-stent restenosis of internal carotid artery covered stent-graft

open access: yesAnnals of Vascular Surgery - Brief Reports and Innovations, 2023
Extracranial carotid artery aneurysms (ECAA) are rare vascular anomalies defined as any aneurysmal dilatation of the common, external, or internal carotid artery leading up to the skull base. Operative management is indicated due to the high incidence of
Michael P. Dorsey   +2 more
doaj   +1 more source

Bindarit inhibits human coronary artery smooth muscle cell proliferation, migration and phenotypic switching [PDF]

open access: yes, 2012
Bindarit, a selective inhibitor of monocyte chemotactic proteins (MCPs) synthesis, reduces neointimal formation in animal models of vascular injury and recently has been shown to inhibit in-stent late loss in a placebo-controlled phase II clinical trial.
Angelo Guglielmotti   +12 more
core   +3 more sources

Home - About - Disclaimer - Privacy